Nanotechnology-Based Cisplatin Intracellular Delivery to Enhance Chemo-Sensitivity of Ovarian Cancer

BACKGROUND: Platinum resistance is a major challenge in the management of ovarian cancer. Even low levels of acquired resistance at the cellular level lead to impaired response to cisplatin. In ovarian cancer intraperitoneal therapy, nanoparticle formulation can improve the cisplatin’s pharmacokinet...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Nanomedicine
Päätekijät: Bortot, Barbara, Mongiat, Maurizio, Valencic, Erica, Dal Monego, Simeone, Licastro, Danilo, Crosera, Matteo, Adami, Gianpiero, Rampazzo, Enrico, Ricci, Giuseppe, Romano, Federico, Severini, Giovanni Maria, Biffi, Stefania
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove 2020
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7368240/
https://ncbi.nlm.nih.gov/pubmed/32764921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S247114
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia